RecruitingPhase 1NCT06551233

Safety and Efficacy of 9MW2821 in the Treatment of High-risk Non-muscle-invasive Bladder Cancer (NMIBC)

Studying Muscular tumor

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Intervention
9MW2821(drug)
Enrollment
30 enrolled
Eligibility
18 years · All sexes
Timeline
20242025

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06551233 on ClinicalTrials.gov

Other trials for Muscular tumor

Additional recruiting or active studies for the same condition.

See all trials for Muscular tumor

← Back to all trials